How should regions of consecutive modified nucleotides be described in a patent application?
According to MPEP 2412.05(b), regions of consecutive modified nucleotides in patent applications should be described as follows: Describe the region in a feature table as required for a modified nucleotide Modified nucleotides in the region can be jointly described in a single INSDFeature element Provide the most restrictive unabbreviated chemical name or a list of…
Read More